Skip to main content
Springer Nature Link
Account
Fig. 5 | Clinical Research in Cardiology

Fig. 5

From: Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

Fig. 5

Relationship between effect size and receptor selectivity of SGLT2i for the combined primary endpoint of hospitalizations for HF or CV death. CI confidence interval, CV cardiovascular, ES effect size, HF heart failure, SGLT2i sodium-glucose cotransporter 2 inhibitor. Each bubble represents an SGLT2i trial. The symbol size represents the sample size of the respective trials

Back to article page